134 related articles for article (PubMed ID: 37204046)
21. Targeting lipid metabolism for ferroptotic cancer therapy.
Luo M; Yan J; Hu X; Li H; Li H; Liu Q; Chen Y; Zou Z
Apoptosis; 2023 Feb; 28(1-2):81-107. PubMed ID: 36399287
[TBL] [Abstract][Full Text] [Related]
22. Intracellular Delivery of Glutathione Peroxidase Degrader Induces Ferroptosis In Vivo.
Luo T; Zheng Q; Shao L; Ma T; Mao L; Wang M
Angew Chem Int Ed Engl; 2022 Sep; 61(39):e202206277. PubMed ID: 35924720
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin.
Zhang X; Sui S; Wang L; Li H; Zhang L; Xu S; Zheng X
J Cell Physiol; 2020 Apr; 235(4):3425-3437. PubMed ID: 31556117
[TBL] [Abstract][Full Text] [Related]
24. Cloning and Characterization of Yak
Xu H; Li Y; Li Q; Ma Z; Yin S; He H; Xiong Y; Xiong X; Lan D; Li J; Fu W
Animals (Basel); 2023 Dec; 13(24):. PubMed ID: 38136869
[TBL] [Abstract][Full Text] [Related]
25. Iron ion and sulfasalazine-loaded polydopamine nanoparticles for Fenton reaction and glutathione peroxidase 4 inactivation for enhanced cancer ferrotherapy.
Zhu X; Chen Q; Xie L; Chen W; Jiang Y; Song E; Song Y
Acta Biomater; 2022 Jun; 145():210-221. PubMed ID: 35470077
[TBL] [Abstract][Full Text] [Related]
26. POLQ inhibition attenuates the stemness and ferroptosis resistance in gastric cancer cells via downregulation of dihydroorotate dehydrogenase.
Peng Y; Zheng W; Chen Y; Lei X; Yang Z; Yang Y; Liang W; Sun K; Li G; Yu J
Cell Death Dis; 2024 Apr; 15(4):248. PubMed ID: 38575587
[TBL] [Abstract][Full Text] [Related]
27. Near Infrared-Activatable Platinum-Decorated Gold Nanostars for Synergistic Photothermal/Ferroptotic Therapy in Combating Cancer Drug Resistance.
Del Valle AC; Yeh CK; Huang YF
Adv Healthc Mater; 2020 Oct; 9(20):e2000864. PubMed ID: 32945131
[TBL] [Abstract][Full Text] [Related]
28. MiR-15a-3p regulates ferroptosis via targeting glutathione peroxidase GPX4 in colorectal cancer.
Liu L; Yao H; Zhou X; Chen J; Chen G; Shi X; Wu G; Zhou G; He S
Mol Carcinog; 2022 Mar; 61(3):301-310. PubMed ID: 34727409
[TBL] [Abstract][Full Text] [Related]
29. Self-Assembled Aza-Boron-Dipyrromethene for Ferroptosis-Boosted Sonodynamic Therapy.
You C; Li X; Wang D; Chen H; Liang L; Chen Y; Zhao Y; Xiang H
Angew Chem Int Ed Engl; 2022 Oct; 61(41):e202210174. PubMed ID: 35981223
[TBL] [Abstract][Full Text] [Related]
30. 17β-oestradiol inhibits ferroptosis in the hippocampus by upregulating DHODH and further improves memory decline after ovariectomy.
Tian Y; Xie Y; Guo Z; Feng P; You Y; Yu Q
Redox Biol; 2023 Jun; 62():102708. PubMed ID: 37116254
[TBL] [Abstract][Full Text] [Related]
31. Luteolin exhibits synergistic therapeutic efficacy with erastin to induce ferroptosis in colon cancer cells through the HIC1-mediated inhibition of GPX4 expression.
Zheng Y; Li L; Chen H; Zheng Y; Tan X; Zhang G; Jiang R; Yu H; Lin S; Wei Y; Wang Y; Zhang R; Liu Z; Wu J
Free Radic Biol Med; 2023 Nov; 208():530-544. PubMed ID: 37717793
[TBL] [Abstract][Full Text] [Related]
32. Ferroptosis in life: To be or not to be.
Xu L; Liu Y; Chen X; Zhong H; Wang Y
Biomed Pharmacother; 2023 Mar; 159():114241. PubMed ID: 36634587
[TBL] [Abstract][Full Text] [Related]
33. Novel Therapeutic Savior for Osteosarcoma: The Endorsement of Ferroptosis.
Qiu C; Liu T; Luo D; Luan D; Cheng L; Wang S
Front Oncol; 2022; 12():746030. PubMed ID: 35402247
[TBL] [Abstract][Full Text] [Related]
34. ZX703: A Small-Molecule Degrader of GPX4 Inducing Ferroptosis in Human Cancer Cells.
Hu M; Li X; Wang L; Zhang Y; Sun Y; Hua H; Liu H; Cai T; Zhu D; Xiang Q
ACS Med Chem Lett; 2024 Mar; 15(3):406-412. PubMed ID: 38505849
[TBL] [Abstract][Full Text] [Related]
35. Lysyl oxidase-like 3 restrains mitochondrial ferroptosis to promote liver cancer chemoresistance by stabilizing dihydroorotate dehydrogenase.
Zhan M; Ding Y; Huang S; Liu Y; Xiao J; Yu H; Lu L; Wang X
Nat Commun; 2023 May; 14(1):3123. PubMed ID: 37253718
[TBL] [Abstract][Full Text] [Related]
36. Ugi reaction-assisted assembly of covalent PROTACs against glutathione peroxidase 4.
Zhu L; Hu S; Yan X; Zeng Q; Zhang B; Jiang L; Yao SQ; Ge J
Bioorg Chem; 2023 May; 134():106461. PubMed ID: 36924654
[TBL] [Abstract][Full Text] [Related]
37. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
[TBL] [Abstract][Full Text] [Related]
38. Directly targeting glutathione peroxidase 4 may be more effective than disrupting glutathione on ferroptosis-based cancer therapy.
Wei Y; Lv H; Shaikh AB; Han W; Hou H; Zhang Z; Wang S; Shang P
Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129539. PubMed ID: 31958545
[TBL] [Abstract][Full Text] [Related]
39. Interplay between MTOR and GPX4 signaling modulates autophagy-dependent ferroptotic cancer cell death.
Liu Y; Wang Y; Liu J; Kang R; Tang D
Cancer Gene Ther; 2021 Feb; 28(1-2):55-63. PubMed ID: 32457486
[TBL] [Abstract][Full Text] [Related]
40. Targeting GPX4 in ferroptosis and cancer: chemical strategies and challenges.
Liu J; Tang D; Kang R
Trends Pharmacol Sci; 2024 Jun; ():. PubMed ID: 38866667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
